P&G, AstraZeneca Sued Over Prilosec OTC Risks
Procter & Gamble Co. and AstraZeneca PLC have been hit with a putative class action alleging that they failed to warn consumers that their over-the-counter heartburn treatment Prilosec OTC can increase...To view the full article, register now.
Already a subscriber? Click here to view full article